What is Papular xanthoma?
Papular xanthoma is an extremely rare non-Langerhans cell histiocytosis classified among the xanthogranuloma family of disorders. It is characterized by the development of multiple small, yellowish to reddish-brown papules or nodules on the skin, typically distributed over the trunk, face, and extremities. Unlike other xanthomatous conditions, papular xanthoma occurs in the absence of lipid metabolism abnormalities — patients typically have normal serum lipid levels. The condition primarily affects the skin without systemic or visceral involvement, distinguishing it from other histiocytic disorders. Histologically, the lesions are composed of foamy (lipid-laden) histiocytes, Touton giant cells, and inflammatory infiltrates. The histiocytes are of non-Langerhans cell origin, meaning they do not express CD1a or Birbeck granules, but they are positive for CD68 and other macrophage markers. The condition is generally benign and self-limited, though lesions may persist or slowly increase in number over time. There is no established standard treatment for papular xanthoma. Management is primarily symptomatic and cosmetic. Individual lesions may be removed by surgical excision, cryotherapy, or laser therapy if desired for aesthetic reasons. Because the condition is benign and does not involve internal organs, the prognosis is excellent. Regular dermatologic follow-up is recommended to monitor for new lesions and to distinguish the condition from other histiocytic proliferative disorders that may have systemic implications.
Clinical phenotype terms— hover any for plain English:
- Eruptive xanthomasHP:0001013
- HistiocytosisHP:0100727
- Inheritance
- Sporadic
- Usually appears on its own, not inherited from a parent
- Age of Onset
- Adult
- Begins in adulthood (age 18 or older)
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Papular xanthoma.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Papular xanthoma at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Papular xanthoma.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Papular xanthoma.
Community
No community posts yet. Be the first to share your experience with Papular xanthoma.
Start the conversation →Latest news about Papular xanthoma
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Papular xanthoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Papular xanthoma
What is Papular xanthoma?
Papular xanthoma is an extremely rare non-Langerhans cell histiocytosis classified among the xanthogranuloma family of disorders. It is characterized by the development of multiple small, yellowish to reddish-brown papules or nodules on the skin, typically distributed over the trunk, face, and extremities. Unlike other xanthomatous conditions, papular xanthoma occurs in the absence of lipid metabolism abnormalities — patients typically have normal serum lipid levels. The condition primarily affects the skin without systemic or visceral involvement, distinguishing it from other histiocytic diso
How is Papular xanthoma inherited?
Papular xanthoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Papular xanthoma typically begin?
Typical onset of Papular xanthoma is adult. Age of onset can vary across affected individuals.
Frequently asked questions about Papular xanthoma
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Papular xanthoma?
Papular xanthoma is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:158008). It is typically inherited as sporadic. Age of onset is generally adult. For verified primary sources, see the UniteRare Papular xanthoma page.
How is Papular xanthoma inherited?
Papular xanthoma follows sporadic inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Papular xanthoma?
Approved treatments for Papular xanthoma are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Papular xanthoma?
Active clinical trials for Papular xanthoma are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Papular xanthoma?
Verified Papular xanthoma specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Papular xanthoma page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.